← Back to Clinical Trials
Recruiting NCT06196307

NCT06196307 Early Warning and Classification Model for Acute Non-traumatic Chest Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06196307
Status Recruiting
Phase
Sponsor Xiao-nan He
Condition Chest Pain
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2022-08-30
Primary Completion 2027-12-30

Trial Parameters

Condition Chest Pain
Sponsor Xiao-nan He
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-08-30
Completion 2027-12-30
Interventions
Clinical evaluation, laboratory and cardiac imaging results, medication, surgery, and any hospitalization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 18 years 2. Symptom onset or worsening within 24 hours before presentation, with a chief complaint of acute chest pain meeting the broad definition of chest pain (2021 AHA) 3. Presentation to the emergency department, with a clinical diagnosis consistent with non-traumatic chest pain 4. Signed informed consent Exclusion Criteria: 1. traumatic chest pain 2. systemic pain caused by malignant tumors or rheumatic diseases involving the chest 3. Patients were lost to follow-up

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology